Syntax Advisors, LLC
- SEC CIK
- 0001858294
- Latest filing
- Nov 13, 2023
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by Syntax Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q3 2023 holdings
- Shares (Q3 2023)
- 282
- Value
- $232.1K
- % of portfolio
- 0.2%
- Quarters held
- 8
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 282 | $232.1K | 0.2% | −25−8.1% | Reduced | Holders |
| Q2 2023 | 307 | $220.6K | 0.2% | −13−4.1% | Reduced | Holders |
| Q1 2023 | 320 | $262.9K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2022 | 320 | $230.9K | 0.2% | −39−10.9% | Reduced | Holders |
| Q3 2022 | 359 | $247.0K | 0.2% | −66−15.5% | Reduced | Holders |
| Q2 2022 | 425 | $251.0K | 0.2% | +66+18.4% | Added | Holders |
| Q1 2022 | 359 | $251.0K | 0.2% | −31−7.9% | Reduced | Holders |
| Q4 2021 | 390 | $246.0K | 0.2% | – | No prior filing | Holders |